Free tool
Healthcare stocks
We cover 451 companies in the Healthcare sector. The median market value in the group is $54.52M. Across the group, the median move over the past trading day is 0.00%. 43% of the 443 with a 200-day average trade above it. Price change over the past year runs from −68.0% to +57.4% across the middle 80 percent of the group, with a median of −17.0%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
451 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| WDH1.DE | Demant A/S | 39.10 EUR | +2.84% | +36.62% | −5.53% |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.63% | +29.07% | +30.59% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| ALK-B.CO | ALK-Abelló A/S | 208.80 DKK | −6.62% | −7.16% | +5.09% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% |
| CTEC.L | Convatec Group PLC | 228.80 GBP | −0.78% | −4.49% | −1.95% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,640.00 GBP | +0.61% | +7.71% | −9.62% |
| OBCK.DE | Ottobock SE & Co. KGaA | 60.40 EUR | +4.50% | +0.68% | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% |
| 22Z.DE | Zealand Pharma A/S | 43.35 EUR | +7.70% | −29.74% | −28.16% |
| ZEAL.CO | Zealand Pharma A/S | 326.90 DKK | +7.15% | −28.95% | −25.94% |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% |
| AFX.DE | Carl Zeiss Meditec AG | 31.92 EUR | +6.33% | −17.62% | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +59.69% |
| AMBU-B.CO | Ambu A/S | 78.40 DKK | +8.59% | −9.10% | −19.13% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| ONT.L | Oxford Nanopore Technologies plc | 183.00 GBP | +62.81% | +42.97% | −2.24% |
| DMP.DE | Dermapharm Holding SE | 42.00 EUR | −1.98% | +8.95% | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| HCM.L | HUTCHMED (China) Limited | 179.00 GBP | +3.17% | −12.25% | −18.08% |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.40 EUR | +8.42% | +52.87% | +53.42% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| ALVO-SDB.ST | Alvotech | 46.45 SEK | +33.67% | +1.57% | −39.57% |
| CLARI.PA | Clariane SE | 4.01 EUR | −0.89% | +2.14% | −6.95% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% |
| NOLA-B.ST | Nolato AB (publ) | 51.80 SEK | +6.91% | −10.27% | −7.00% |
| RDC.DE | Redcare Pharmacy NV | 62.05 EUR | −10.46% | −6.06% | −23.82% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | 6.50 EUR | −2.99% | −48.41% | −48.41% |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| UPR.L | Uniphar plc | 370.00 GBP | −1.33% | +23.75% | +6.94% |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% |
| IVA.PA | Inventiva S.A. | 4.09 EUR | +3.94% | +0.99% | −14.63% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +13.08% | +15.81% | +24.49% |
| TTALO.HE | Terveystalo Oyj | 7.78 EUR | +4.29% | −16.20% | −22.31% |
| SPH.WA | Sopharma AD | 7.76 PLN | +8.08% | −39.14% | −38.71% |
| PHIL.MI | Philogen S.p.A. | 23.85 EUR | +1.06% | +6.10% | +4.75% |
| GUBRA.CO | Gubra A/S | 402.40 DKK | +6.23% | −24.64% | +4.79% |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% |
| MEDCL.PA | MedinCell S.A. | 24.58 EUR | −6.18% | −0.57% | +41.92% |
| VETO.PA | Vetoquinol SA | 70.60 EUR | −3.29% | −16.35% | −6.37% |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% |
| NEU.WA | NEUCA S.A. | 758.00 PLN | +1.34% | −9.22% | +15.02% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| PHN.MI | Pharmanutra S.p.A. | 81.50 EUR | −1.81% | +53.54% | +70.46% |
| DBV.PA | DBV Technologies S.A. | 2.53 EUR | +5.42% | −22.51% | +60.13% |
| SYNSAM.ST | Synsam AB (publ) | 59.50 SEK | +5.50% | −7.98% | +5.66% |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% |
| SFL.MI | Safilo Group S.p.A. | 1.85 EUR | +14.02% | −5.33% | +20.65% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% |
| SNT.WA | Synektik Spólka Akcyjna | 338.40 PLN | −5.58% | +21.82% | +53.07% |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% |
| LBIRD.PA | Lumibird SA | 25.80 EUR | −1.53% | +23.06% | +57.43% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| VLA.PA | Valneva SE | 2.89 EUR | +31.25% | −23.68% | −24.48% |
| AYJ.DE | Valneva SE | 2.98 EUR | +35.29% | −23.93% | −21.89% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −1.02% | −24.08% | −25.98% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% |
| BOI.PA | Boiron SA | 25.80 EUR | −5.84% | −14.29% | +21.99% |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.04 EUR | +0.97% | −90.91% | −90.91% |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.81 EUR | +8.00% | +386.49% | +1198.08% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | −5.08% | −52.94% | −30.00% |
| CVX.PA | Carvolix SA | 7.18 EUR | +17.70% | +293.42% | +293.42% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| AVCT.L | Avacta Group Plc | 69.50 GBP | +0.72% | +20.87% | +26.36% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| FYB.DE | Formycon AG | 18.44 EUR | −2.64% | −29.35% | −25.04% |
| LNA.PA | LNA Santé SA | 33.90 EUR | −2.87% | +38.37% | +11.88% |
| M12.DE | M1 Kliniken AG | 18.36 EUR | −2.86% | +1.10% | +37.84% |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| VOX.WA | Voxel S.A. | 134.20 PLN | +6.85% | +10.36% | −18.11% |
| N3B.F | Anbio Biotechnology | 6.40 EUR | −24.26% | −62.13% | −83.42% |
| ALCLS.PA | Cellectis S.A. | 2.94 EUR | +16.59% | −30.30% | +27.74% |
| OPT.L | Optima Health plc | 240.50 GBP | +1.48% | +20.85% | +9.32% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| ILM1.DE | Medios AG | 10.92 EUR | −1.62% | −25.61% | −26.32% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.50 EUR | +8.87% | −48.77% | +47.70% |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.74 SEK | −0.74% | −2.19% | −1.29% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −9.00% | −21.91% | +16.89% |
| PIHLIS.HE | Pihlajalinna Oyj | 10.92 EUR | +5.61% | −21.46% | −28.38% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| TSTL.L | Tristel plc | 425.00 GBP | +1.19% | −2.84% | +19.76% |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% |
| TNG.PA | Transgene SA | 0.81 EUR | +12.57% | −15.34% | −22.50% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| ALMDT.PA | Median Technologies SA | 4.57 EUR | +15.84% | +3.98% | +90.42% |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% |
| CLN.WA | Celon Pharma S.A. | 22.20 PLN | +5.21% | +8.82% | −3.06% |
| ALERS.PA | Eurobio Scientific Société anonyme | 19.80 EUR | −6.60% | −18.01% | −21.89% |
| STIL.ST | Stille AB | 225.00 SEK | −5.06% | +16.58% | −4.26% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| ICE.WA | Medinice S.A. | 72.30 PLN | −6.35% | +330.36% | +595.19% |
| NORDH.OL | Nordhealth AS | 24.40 NOK | 0.00% | −32.22% | −32.22% |
| LIK.DE | LIMES Schlosskliniken AG | 570.00 EUR | −0.87% | +58.33% | +70.66% |
| ORIOLA.HE | Oriola Oyj | 0.90 EUR | −0.33% | −20.66% | −21.98% |
| BLC.PA | Bastide Le Confort Médical SA | 22.30 EUR | −2.83% | −6.50% | −16.32% |
| CARA.ST | Carasent AB (publ) | 25.25 SEK | +1.00% | −5.78% | −10.62% |
| FLERIE.ST | Flerie AB (publ) | 19.25 SEK | −3.02% | −40.94% | −48.05% |
| SANION.ST | Saniona AB (publ) | 11.83 SEK | −15.32% | −43.93% | −12.37% |
| DXRX.L | Diaceutics PLC | 143.50 GBP | +8.71% | +11.67% | +4.36% |
| ALCGM.PA | Cegedim SA | 10.26 EUR | +1.38% | −25.92% | −4.56% |
| VME.DE | Viromed Medical AG | 6.50 EUR | −15.03% | +71.96% | +85.71% |
| ALSEN.PA | Sensorion SA | 0.28 EUR | −0.71% | −17.01% | −14.20% |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% |
| NYKD.OL | Nykode Therapeutics AS | 4.64 NOK | +45.68% | +96.94% | +204.86% |
| PHO.OL | Photocure ASA | 54.00 NOK | −0.18% | −24.90% | −13.46% |
| ENE.WA | Centrum Medyczne ENEL-MED S.A. | 20.00 PLN | −0.99% | +11.11% | +16.28% |
| S2B.WA | Syn2bio S.A. | 63.00 PLN | −9.12% | +76.47% | +76.47% |
| MRC.WA | Mercator Medical S.A. | 60.40 PLN | +18.43% | +52.53% | +35.88% |
| CRNO-B.ST | Cereno Scientific AB (publ) | 4.71 SEK | +0.13% | −32.04% | −53.59% |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% |
| GENO.ST | Genovis AB (publ.) | 20.15 SEK | +2.81% | −7.36% | −16.91% |
| V5P.F | Vytrus Biotech, S.A. | 17.60 EUR | +1.73% | +67.62% | +225.93% |
| EKF.L | EKF Diagnostics Holdings plc | 24.70 GBP | −5.00% | −6.97% | −15.56% |
| PAX.ST | Paxman AB (publ) | 57.50 SEK | +26.37% | +2.68% | −21.45% |
| SCLP.L | Scancell Holdings plc | 9.70 GBP | −2.02% | −2.02% | −7.62% |
| SLV.WA | Selvita S.A. | 28.60 PLN | +7.52% | −35.29% | −9.21% |
| HPHA.DE | Heidelberg Pharma AG | 2.52 EUR | −2.70% | +0.80% | −31.15% |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% |
| MVIR.ST | Medivir AB (publ) | 2.08 SEK | +14.29% | +351.19% | +4.73% |
| XI3.F | Bioceltix S.A. | 20.40 EUR | +7.59% | −16.22% | −28.67% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | 74.00 PLN | −0.80% | −1.33% | +80.49% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| CRAD-B.ST | C-Rad AB (publ) | 35.30 SEK | −4.08% | +11.00% | +6.49% |
| HAMLET-B.ST | Hamlet BioPharma AB (publ) | 6.10 SEK | −17.57% | +7.02% | −0.81% |
| BCX.WA | Bioceltix S.A. | 80.50 PLN | −17.01% | 0.00% | −20.77% |
| SCP.WA | Scope Fluidics S.A. | 140.20 PLN | +19.83% | +0.29% | −9.90% |
| S84.F | Scope Fluidics S.A. | 27.90 EUR | +19.74% | −25.50% | −10.43% |
| RVU.WA | Ryvu Therapeutics S.A. | 18.40 PLN | +22.67% | −32.23% | −36.99% |
| GBT.PA | Guerbet SA | 7.92 EUR | +3.80% | −46.41% | −61.92% |
| SYNACT.ST | SynAct Pharma AB | 19.66 SEK | +12.99% | −12.43% | +10.82% |
| FARON.HE | Faron Pharmaceuticals Oy | 0.48 EUR | −0.92% | −78.79% | −79.42% |
| AZT.OL | ArcticZymes Technologies ASA | 20.80 NOK | +5.05% | −1.89% | −27.02% |
| ALCJ.PA | Crossject Société Anonyme | 1.48 EUR | −0.67% | −31.00% | −2.63% |
| FARN.L | Faron Pharmaceuticals Oy | 41.00 GBP | −4.65% | −78.97% | −79.24% |
| ALECR.PA | Eurofins-Cerep SA | 17,700.00 EUR | +8.59% | −0.56% | −3.80% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% |
| EAPI.PA | Euroapi S.A. | 0.95 EUR | −24.88% | −56.91% | −68.63% |
| 4BB.L | 4basebio PLC | 470.00 GBP | −10.48% | −23.58% | −46.89% |
| ABNX.PA | ABIONYX Pharma SA | 1.97 EUR | +5.79% | −49.58% | −31.34% |
| 88Q.DE | 4basebio PLC | 5.35 EUR | −3.60% | −20.15% | −45.69% |
| NANOFH.HE | Nanoform Finland Oyj | 0.96 EUR | +9.34% | −18.64% | +15.66% |
| ADOC.PA | Adocia SA | 4.01 EUR | −0.20% | −40.42% | −54.33% |
| NANOFS.ST | Nanoform Finland Oyj | 10.94 SEK | +15.40% | −15.06% | +19.56% |
| BIOPOR.CO | BioPorto A/S | 1.24 DKK | +2.48% | +19.00% | −3.13% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | 68.60 SEK | +3.94% | +37.75% | +15.88% |
| VISTN.OL | Vistin Pharma ASA | 19.15 NOK | −5.67% | −1.74% | −15.42% |
| EAH.L | ECO Animal Health Group plc | 99.00 GBP | +1.54% | −6.60% | +34.69% |
| 7V0.DE | Novogenia AG | 6.40 EUR | +7.56% | −16.34% | −25.00% |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% |
| NANEXA.ST | Nanexa AB (publ) | 4.63 SEK | +14.46% | +15.03% | +100.43% |
| EQL.ST | EQL Pharma AB (publ) | 27.05 SEK | +34.58% | −54.31% | −67.01% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | 6.40 SEK | +4.23% | +220.80% | +78.27% |
| CREO.L | Creo Medical Group PLC | 12.88 GBP | −5.50% | +26.85% | −1.90% |
| POLB.L | Poolbeg Pharma PLC | 8.60 GBP | +36.51% | +120.51% | +164.62% |
| HIGH.DE | Cantourage Group SE | 6.00 EUR | +5.63% | +80.72% | +51.90% |
| OMDA.OL | Omda AS | 36.00 NOK | −2.17% | −24.61% | −23.98% |
| OBI.L | Ondine Biomedical Inc. | 11.75 GBP | −14.55% | +34.29% | −24.19% |
| INIFY.OL | INIFY Laboratories AB | 7.95 NOK | −3.05% | +65.63% | +44.55% |
| NXTMH.HE | Nexstim Plc | 9.28 EUR | −4.03% | −33.71% | −26.64% |
| AB.PA | AB Science S.A. | 0.74 EUR | +32.68% | −49.38% | −38.62% |
| DICOT.ST | Dicot Pharma AB | 0.21 SEK | +13.89% | −32.06% | −76.06% |
| MDG.WA | Medicalgorithmics S.A. | 28.85 PLN | +15.40% | −15.89% | −20.30% |
| KOO.L | Kooth plc | 146.00 GBP | −3.63% | +26.96% | −7.59% |
| STX.L | Shield Therapeutics plc | 4.85 GBP | −15.65% | −50.76% | −37.42% |
| ALTHX.PA | THX Pharma Société Anonyme | 4.18 EUR | +5.16% | +83.92% | +73.96% |
| ZLNA.OL | Zelluna ASA | 21.70 NOK | −2.25% | +55.00% | +56.57% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | 13.70 SEK | +13.41% | −28.65% | −11.27% |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% |
| GENT.OL | Gentian Diagnostics ASA | 39.00 NOK | 0.00% | −30.89% | −30.41% |
| MAAT.PA | MaaT Pharma SA | 3.04 EUR | +8.96% | −45.52% | −33.91% |
| LYTIX.OL | Lytix Biopharma ASA | 7.78 NOK | −11.59% | −22.04% | −4.19% |
| AJ91.DE | DocCheck AG | 10.90 EUR | −6.03% | −13.49% | −9.92% |
| HEALTH.HE | Nightingale Health Oyj | 0.93 EUR | +9.95% | −55.38% | −57.24% |
| R0L.F | J Frontier Co.,Ltd. | 10.30 EUR | +10.75% | −44.02% | −44.02% |
| ALGAE.PA | Fermentalg SA | 0.46 EUR | −5.46% | +6.62% | −10.00% |
| SEZI.ST | Senzime AB (publ) | 3.78 SEK | +3.28% | −30.35% | −39.98% |
| HVO.L | hVIVO plc | 6.50 GBP | −10.34% | +1.56% | −35.00% |
| V3V.DE | FamiCord AG | 2.86 EUR | +0.70% | −52.73% | −61.35% |
| ALTHE.PA | Theraclion SA | 0.63 EUR | +6.55% | +3.93% | −22.30% |
| ALSMA.PA | S.M.A.I.O S.A. | 7.60 EUR | −2.56% | +23.58% | +14.29% |
| ALKLH.PA | Klea Holding SA | 0.15 EUR | −4.73% | −31.24% | −32.00% |
| BVC.L | BATM Advanced Communications Ltd. | 12.30 GBP | −3.91% | −23.36% | −21.90% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 588.00 GBP | −8.12% | +3.52% | +70.43% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +37.70% | +90.12% | +71.52% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| MOB.ST | Moberg Pharma AB (publ) | 10.70 SEK | +9.52% | +4.49% | +32.92% |
| FLUO.ST | FluoGuide A/S | 33.40 SEK | +6.71% | −9.49% | −18.34% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% |
| MODU.HE | Modulight Oyj | 1.07 EUR | −0.47% | −7.87% | −19.92% |
| XSPRAY.ST | Xspray Pharma AB (publ) | 10.74 SEK | −35.77% | −64.61% | −76.00% |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% |
| SVS.MI | Svas Biosana S.p.A. | 8.24 EUR | −5.07% | +3.00% | +0.98% |
| M3V.DE | MeVis Medical Solutions AG | 23.80 EUR | +2.59% | +0.39% | −0.42% |
| HRTIS.HE | Herantis Pharma Oyj | 1.69 EUR | +6.42% | −26.20% | −2.31% |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −9.52% | −20.83% | −26.92% |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% |
| SVE.WA | Synthaverse S.A. | 3.06 PLN | +9.29% | −20.21% | −36.25% |
| BIOBV.HE | Biohit Oyj | 2.60 EUR | −6.14% | −27.78% | −8.13% |
| IMMU.ST | Mendus AB (publ) | 7.10 SEK | +2.60% | +23.05% | −4.57% |
| CLBIO.ST | Corline Biomedical AB | 18.85 SEK | +6.80% | +8.96% | +45.56% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.40 EUR | −2.44% | −37.50% | −46.67% |
| OSSD.ST | OssDsign AB (publ) | 4.00 SEK | −10.01% | −64.60% | −73.26% |
| ENZY.ST | Enzymatica AB (publ) | 1.90 SEK | +4.97% | −1.04% | −20.17% |
| MPAL.L | MedPal AI PLC | 3.75 GBP | +22.95% | −25.00% | −40.00% |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% |
| ALCOX.PA | Nicox S.A. | 0.38 EUR | +0.79% | +21.76% | +2.70% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| NCYT.L | Novacyt S.A. | 43.50 GBP | +17.73% | +21.00% | +7.81% |
| OPTOMED.HE | Optomed Oyj | 1.71 EUR | +6.36% | −54.99% | −54.39% |
| PMED.MI | PiùMedical S.p.A. | 5.60 EUR | −4.27% | −6.67% | −3.55% |
| MOC.WA | Molecure S.A. | 6.03 PLN | −2.58% | −8.08% | −22.39% |
| MNTC.ST | Mentice AB (publ) | 12.75 SEK | −13.85% | −4.85% | −6.59% |
| IVACC.ST | Intervacc AB (publ) | 1.10 SEK | −14.11% | +17.98% | +4.78% |
| ORT-B.ST | Ortoma AB (publ) | 7.80 SEK | −13.24% | −42.22% | −66.52% |
| NAVA.OL | Navamedic ASA | 14.90 NOK | −8.31% | −35.22% | −32.27% |
| ALMKT.PA | Mauna Kea Technologies SA | 0.15 EUR | −0.39% | +95.44% | +47.33% |
| ABDX.L | Abingdon Health Plc | 10.75 GBP | +4.88% | +67.97% | +104.76% |
| QLINEA.ST | Q-linea AB (publ) | 18.70 SEK | +8.41% | −35.52% | −62.97% |
| SPRINT.ST | Sprint Bioscience AB (publ) | 3.15 SEK | −15.32% | +111.41% | +458.51% |
| ALGEN.PA | genOway Société anonyme | 2.46 EUR | −0.81% | −8.89% | −18.00% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | 3.31 SEK | −10.78% | +14.53% | +4.75% |
| PTG.WA | Poltreg S.A. | 25.00 PLN | +9.17% | −1.96% | −14.68% |
| BXT.DE | BioNxt Solutions Inc. | 0.22 EUR | +5.26% | −48.72% | −65.52% |
| MAB.WA | Mabion S.A. | 7.72 PLN | +4.04% | +5.90% | −16.99% |
| AREC.L | Arecor Therapeutics plc | 66.00 GBP | +3.94% | −22.35% | +3.94% |
| BRETEC.HE | Bioretec Oy | 0.02 EUR | +5.77% | −96.58% | −98.25% |
| PXS.L | Provexis plc | 1.09 GBP | −7.63% | +23.16% | +51.39% |
| BRAIN.ST | BrainCool AB (publ) | 0.73 SEK | −1.22% | +21.87% | −21.51% |
| SIGHT.PA | GenSight Biologics S.A. | 0.12 EUR | +46.83% | +5.61% | −25.31% |
| ACARIX.ST | Acarix AB (publ) | 0.24 SEK | −3.99% | −10.93% | −14.11% |
| IMM.L | ImmuPharma plc | 3.41 GBP | −24.22% | −45.00% | +89.66% |
| ALIMP.PA | Implanet S.A. | 0.19 EUR | +13.05% | −8.35% | −2.68% |
| ALDVI.PA | Advicenne S.A. | 1.75 EUR | +4.79% | −6.02% | +39.11% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% |
| ALDMS.PA | Diagnostic Medical Systems S.A. | 1.05 EUR | −1.42% | −18.68% | −25.62% |
| GDR.L | genedrive plc | 1.30 GBP | +33.33% | +48.57% | +67.74% |
| CONTX.OL | ContextVision AB (publ) | 3.55 NOK | +3.20% | −14.46% | −21.11% |
| NNG.WA | NanoGroup S.A. | 2.38 PLN | −4.80% | −11.19% | −17.36% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −5.38% | +19.81% | −4.90% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | 1.75 SEK | +32.27% | −13.13% | −44.31% |
| SOFTX.OL | SoftOx Solutions AS | 0.10 NOK | +16.03% | +13.60% | −15.04% |
| ALIKO.PA | Ikonisys S.A. | 1.42 EUR | −5.33% | −12.07% | −6.58% |
| ISOFOL.ST | Isofol Medical AB (publ) | 0.84 SEK | +5.79% | +12.60% | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | 1.05 SEK | +32.58% | +50.57% | +97.38% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| AAQ1.DE | aap Implantate AG | 1.46 EUR | −7.01% | +6.57% | −15.12% |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% |
| RUA.L | RUA Life Sciences plc | 28.00 GBP | +9.80% | +103.64% | +130.93% |
| IXI.L | IXICO plc | 7.75 GBP | −8.82% | −34.04% | −36.73% |
| ALTAO.PA | Aton | 0.02 EUR | +94.12% | +182.86% | +153.85% |
| COG.L | Cambridge Cognition Holdings Plc | 31.00 GBP | −6.06% | +10.71% | −4.62% |
| IHC.L | Inspiration Healthcare Group plc | 18.30 GBP | −1.08% | +24.07% | −19.74% |
| MAK.DE | Maternus-Kliniken Aktiengesellschaft | 0.92 EUR | −3.16% | −6.60% | −22.03% |
| SCIB.ST | SciBase Holding AB (publ) | 20.40 SEK | −34.19% | −18.40% | −29.25% |
| X74.F | I.M.D. International Medical Devices S.p.A. | 1.02 EUR | −9.73% | −21.02% | −22.17% |
| DEX.ST | Dextech Medical AB | 10.30 SEK | −0.96% | +11.35% | +26.38% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | 9.36 SEK | −6.40% | −9.77% | −72.31% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| ALBIO.PA | Biosynex SA | 0.90 EUR | −0.88% | +56.06% | −23.23% |
| FAB.L | Fusion Antibodies plc | 11.25 GBP | +9.76% | −16.67% | −23.73% |
| ORTI-A.ST | Ortivus AB (publ) | 2.00 SEK | +6.38% | +52.67% | −35.48% |
| ELIC.ST | Elicera Therapeutics AB (publ) | 2.70 SEK | +13.71% | −47.97% | −61.50% |
| ALINS.PA | Intrasense S.A. | 0.30 EUR | +34.55% | +29.26% | −0.34% |
| URT.WA | Urteste S.A. | 43.70 PLN | −6.42% | +2.82% | −15.31% |
| ALTME.PA | TME Pharma N.V. | 0.13 EUR | +113.11% | +88.41% | +25.97% |
| ALZ.ST | Alzinova AB (publ) | 0.84 SEK | −13.70% | +0.48% | −39.02% |
| ABERA.ST | Abera Bioscience AB | 8.18 SEK | −2.62% | +13.61% | +1.61% |
| SENZA.ST | SenzaGen AB | 5.10 SEK | −3.41% | −15.00% | −17.48% |
| INIT.ST | Initiator Pharma A/S | 2.47 SEK | +9.78% | −18.75% | −27.35% |
| B8FK.DE | Biofrontera AG | 2.53 EUR | −0.78% | −0.78% | −3.07% |
| GMT.WA | Genomtec S.A. | 3.68 PLN | −8.80% | −2.39% | −40.65% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | 18.70 SEK | −3.86% | +34.05% | +3.31% |
| PEG.CO | Pharma Equity Group A/S | 0.09 DKK | −5.56% | −19.81% | −38.85% |
| DMYD-B.ST | Diamyd Medical AB (publ) | 1.03 SEK | −0.39% | −91.17% | −90.97% |
| ALEMG.PA | Laboratoires Euromedis Société anonyme | 4.96 EUR | −3.69% | +26.53% | +18.10% |
| PRO.ST | Promimic AB (publ) | 8.50 SEK | −18.27% | −44.98% | −41.38% |
| XINT.ST | Xintela AB (publ) | 0.18 SEK | −8.31% | −37.88% | −51.08% |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% |
| 7820.F | Scandinavian Real Heart AB (Publ) | 1.59 EUR | −1.85% | −32.05% | +1.60% |
| VIRO.CO | ViroGates A/S | 9.90 DKK | +1.02% | −26.67% | −1.00% |
| THAT.L | Thalia Therapeutics Plc | 0.65 GBP | −3.70% | +23.81% | +52.94% |
| GME.DE | Geratherm Medical AG | 2.58 EUR | +1.18% | −10.42% | −16.50% |
| GENF.L | Genflow Biosciences plc | 2.00 GBP | +23.08% | +2.56% | +166.67% |
| APTA.L | Aptamer Group PLC | 0.38 GBP | −21.05% | −63.94% | −62.50% |
| ORTI-B.ST | Ortivus AB (publ) | 1.62 SEK | −13.83% | +32.79% | +42.11% |
| POXEL.PA | Poxel S.A. | 0.21 EUR | +7.11% | −7.16% | −34.76% |
| ACTI.ST | Active Biotech AB (publ) | 5.50 SEK | +6.38% | +19.57% | −62.00% |
| OBSRV.OL | Observe Medical ASA | 1.00 NOK | −5.85% | +42.57% | +5.05% |
| NICA.ST | Nanologica AB (publ) | 0.44 SEK | −3.30% | −41.33% | −69.86% |
| PTRK.ST | Physitrack PLC | 8.06 SEK | −0.49% | −38.71% | −57.58% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.45 SEK | −9.46% | +4.41% | −30.12% |
| IZAFE-B.ST | iZafe Group AB (publ) | 0.31 SEK | 0.00% | −33.26% | −17.57% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | 0.10 SEK | −23.09% | +125.34% | −28.35% |
| ACUC.ST | AcuCort AB (publ) | 0.55 SEK | −13.44% | −13.44% | −5.94% |
| NOSA.ST | Nosa Plugs AB | 0.47 SEK | −5.81% | −18.83% | −35.62% |
| ALNFL.PA | NFL Biosciences SA | 0.90 EUR | +7.96% | −25.42% | −39.12% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.19 SEK | −12.36% | −39.58% | −47.36% |
| ICO.ST | Iconovo AB (publ) | 1.26 SEK | +26.00% | +12.50% | −52.09% |
| LIFE.OL | Lifecare ASA | 0.30 NOK | −11.94% | −51.51% | −97.23% |
| NXTCL.ST | NextCell Pharma AB | 1.12 SEK | +4.69% | +58.97% | −5.10% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| SMSMED.CO | Scandinavian Medical Solutions A/S | 3.01 DKK | +7.12% | −32.05% | −28.33% |
| ARCOMA.ST | Arcoma AB | 8.26 SEK | +2.74% | +14.72% | −2.13% |
| ALBPS.PA | Biophytis S.A. | 0.08 EUR | +422.88% | +28.41% | −50.31% |
| SVNS.L | Solvonis Therapeutics plc | 0.12 GBP | −11.59% | −61.88% | −55.64% |
| BMX.WA | BioMaxima S.A. | 10.14 PLN | +1.71% | −17.89% | −20.78% |
| F98.F | CytoMed Therapeutics Limited | 0.84 EUR | +12.08% | −73.06% | −50.30% |
| ALSGD.PA | SpineGuard SA | 0.10 EUR | +13.91% | +1.93% | +8.08% |
| VIVE.ST | Vivesto AB | 8.90 SEK | +3.01% | −21.10% | −57.13% |
| ONCOZ.ST | OncoZenge AB (publ) | 5.68 SEK | −15.85% | −13.81% | −14.59% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | 13.60 SEK | +7.09% | −31.66% | −46.03% |
| ALAMA.PA | AMA Corporation Plc | 0.17 EUR | +21.07% | −0.59% | −34.56% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | 3.05 SEK | −4.69% | −33.84% | −19.74% |
| IMMNOV.ST | Immunovia AB (publ) | 0.15 SEK | −15.58% | −33.66% | −70.74% |
| BIBB.ST | BiBBInstruments AB | 0.59 SEK | −14.70% | −83.74% | −84.94% |
| IDLDX.ST | IDL Diagnostics AB (publ) | 0.41 SEK | −3.28% | +19.36% | −2.36% |
| SPAGO.ST | Spago Nanomedical AB (publ) | 0.12 SEK | +1.32% | +4.55% | −54.00% |
| EXTX.OL | EXACT Therapeutics AS | 0.75 NOK | +13.64% | −47.55% | −65.60% |
| PHR.WA | Pharmena S.A. | 3.14 PLN | +1.62% | +18.49% | −8.72% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | 1.86 SEK | −3.83% | −72.67% | −75.86% |
| GENI.L | GENinCode Plc | 0.90 GBP | +12.50% | −62.50% | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.61 SEK | +16.48% | −81.26% | −88.08% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | 2.57 SEK | −6.55% | +110.66% | −0.39% |
| PRE.MI | Predict S.p.A. | 0.93 EUR | +3.33% | +19.23% | +7.51% |
| ABS.OL | Arctic Bioscience AS | 2.86 NOK | +2.14% | −21.86% | −30.24% |
| OPTI.L | OptiBiotix Health Plc | 5.65 GBP | −1.74% | −16.30% | −51.91% |
| ABTEC.OL | Aqua Bio Technology ASA | 4.90 NOK | +0.41% | −79.58% | −87.89% |
| PILA.ST | Pila Pharma AB (publ) | 1.68 SEK | +45.45% | −17.24% | −15.41% |
| PRM.L | Proteome Sciences plc | 1.59 GBP | −11.94% | −44.39% | −44.39% |
| CODE.OL | CodeLab Capital AS | 3.40 NOK | +5.59% | +41.67% | +22.74% |
| AWM.WA | Airway Medix S.A. | 0.27 PLN | +0.56% | −21.57% | −31.11% |
| ERMA.ST | Enorama Pharma AB (publ) | 0.89 SEK | +193.73% | −55.16% | −67.04% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | 0.32 EUR | +2.57% | −18.41% | −19.44% |
| CHOSA.ST | Chosa Oncology AB | 0.73 SEK | −14.15% | −20.00% | −9.00% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| MLLAB.PA | Media Lab S.p.A. | 2.50 EUR | −21.88% | −30.17% | −25.60% |
| SYNT.ST | SyntheticMR AB (publ) | 0.72 SEK | +24.14% | −46.07% | −74.29% |
| OBD.L | Oxford BioDynamics Plc | 0.12 GBP | −1.60% | −50.80% | −74.11% |
| ACOU.ST | AcouSort AB (publ) | 2.77 SEK | −23.48% | −14.77% | −18.29% |
| STENO.CO | Stenocare A/S | 0.95 DKK | −1.86% | −36.11% | −22.91% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | 0.37 SEK | +0.54% | +19.35% | −85.49% |
| PEXA-B.ST | PExA AB (publ) | 0.34 SEK | −31.80% | +48.26% | +79.47% |
| SBX.DE | SynBiotic SE | 0.74 EUR | −32.10% | −71.02% | −76.63% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| NFX.L | Nuformix plc | 0.16 GBP | +6.71% | −46.10% | +80.68% |
| STRAP.CO | Strategic Partners A/S | 740.00 DKK | +2.07% | +0.27% | −28.50% |
| ALPAT.PA | Plant Advanced Technologies SA | 4.20 EUR | 0.00% | −48.91% | −53.33% |
| QLIFE.ST | Qlife Holding AB (publ) | 1.81 SEK | −6.91% | −30.80% | −52.47% |
| NEOLA.ST | Neola Medical AB (publ) | 0.49 SEK | −17.67% | −54.05% | −79.24% |
| TCF.L | Theracryf Plc | 0.19 GBP | −2.56% | −5.00% | −20.83% |
| REDS.ST | Redsense Medical AB (publ) | 3.23 SEK | −19.05% | −24.71% | −39.96% |
| ALSPW.PA | Spineway SA | 0.13 EUR | −1.90% | −12.99% | +3.24% |
| SUN.L | Surgical Innovations Group plc | 0.43 GBP | −15.00% | −5.56% | −39.29% |
| BIOSGN.ST | Biosergen AB (publ) | 2.48 SEK | +262.31% | −93.80% | −94.62% |
| ODI.ST | ODI Pharma AB (publ) | 2.20 SEK | −5.17% | −48.36% | +39.24% |
| SDOS.ST | ScandiDos AB (publ) | 0.86 SEK | +3.61% | −25.22% | −34.85% |
| SERV.ST | Servana AB | 0.01 SEK | −16.22% | +210.00% | +106.67% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | −7.50% | −64.98% | −65.74% |
| FLUI.ST | Fluicell AB (publ) | 34.60 SEK | +14.57% | +246.00% | +247.74% |
| KONT.ST | Kontigo Care AB (publ) | 1.33 SEK | −8.62% | −26.39% | −42.39% |
| ALBLU.PA | Bluelinea Société Anonyme | 0.17 EUR | −23.18% | −65.79% | −68.11% |
| AINO.ST | Aino Health AB (publ) | 0.20 SEK | +2.06% | +3.66% | −10.81% |
| FDBK.L | Feedback plc | 6.85 GBP | +13.22% | −36.28% | −48.30% |
| INDCT.OL | Induct AS | 0.77 NOK | −12.47% | −83.00% | −78.07% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | 0.16 SEK | +30.42% | +16.79% | +11.79% |
| PMED.ST | PEPTONIC medical AB (publ) | 0.00 SEK | +20.00% | −25.00% | −25.00% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.38 SEK | −0.36% | −91.79% | −93.99% |
| PYC.L | Physiomics Plc | 0.52 GBP | +7.29% | +80.70% | +21.18% |
| FUM.L | Futura Medical plc | 0.39 GBP | −2.26% | −68.29% | −95.67% |
| MONSO.CO | Monsenso A/S | 0.26 DKK | −19.25% | +73.33% | +23.81% |
| SPERM.ST | Spermosens AB (publ) | 0.01 SEK | −10.20% | +57.14% | +15.79% |
| GUARD.ST | Disruptive Pharma AB (publ) | 1.47 SEK | −10.49% | +1.94% | −93.53% |
| BSFA.L | BSF Enterprise Plc | 1.15 GBP | +43.75% | −39.47% | −48.89% |
| PROGEN.ST | Prostatype Genomics AB (publ) | 0.16 SEK | −4.59% | −59.48% | −79.42% |
| VAL.L | ValiRx plc | 0.16 GBP | +3.33% | −57.53% | −73.04% |
| PERP-B.ST | Perpetua Medical AB (publ) | 3.04 SEK | −18.50% | −41.54% | −35.32% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | 0.97 SEK | +1.58% | −13.06% | −59.79% |
| SPEC.ST | SpectraCure AB (publ) | 0.03 SEK | −3.33% | −79.63% | −81.77% |
| IBAI.L | Imaging Biometrics Ltd. | 0.64 GBP | +5.83% | −25.29% | +2.42% |
| POLAR.ST | PolarCool AB (publ) | 1.73 SEK | +8.12% | −55.87% | −67.96% |
| GABA.ST | Gabather AB (publ) | 0.03 SEK | +10.00% | +6.94% | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | 0.70 SEK | +16.33% | −27.14% | −58.08% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| ADV.WA | Adiuvo Investments S.A. | 0.53 PLN | +13.49% | −7.34% | −34.08% |
| RESP.ST | Respiratorius AB (publ) | 2.28 SEK | +3.17% | +31.03% | −39.20% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | 0.10 SEK | +6.95% | −69.51% | −22.48% |
| 27N0.DE | Cannovum Cannabis AG | 0.56 EUR | +10.76% | +24.94% | +22.47% |
| BIG1.DE | Bio-Gate AG | 2.83 EUR | −14.39% | +262.18% | +200.53% |
| APTA.ST | Aptahem AB (publ) | 0.56 SEK | −15.96% | −51.69% | −67.65% |
| MONI.ST | Monivent AB | 0.17 SEK | −5.71% | −49.39% | −37.02% |
| NANECH.ST | NanoEcho AB (publ) | 0.03 SEK | −3.51% | −57.96% | −72.03% |
| CHLL.L | Chill Brands Group PLC | 2.00 GBP | −9.09% | −74.19% | −87.88% |
| ALINT.PA | IntegraGen SA | 0.18 EUR | −18.86% | +32.22% | −36.25% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| ODIN.ST | Odinwell AB (publ) | 0.14 SEK | −25.80% | −50.71% | −61.25% |
| PTP.DE | Pentixapharm Holding AG | 1.85 EUR | −5.61% | +20.13% | +5.47% |
| LXB.ST | Luxbright AB (publ) | 0.06 SEK | −42.86% | −88.33% | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | 0.40 SEK | −25.93% | −97.66% | −98.15% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | 0.14 SEK | −35.19% | −70.34% | −73.58% |
| TRLS.L | Trellus Health plc | 0.04 GBP | +3233.33% | −90.00% | −94.29% |
| S2M.ST | S2Medical AB (publ) | 0.00 SEK | −11.11% | −52.00% | −63.08% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | 0.47 SEK | +16.75% | −41.99% | −72.69% |
| ALSAF.PA | Safe Orthopaedics SA | 0.64 EUR | 0.00% | −61.90% | −73.33% |
| SDET.ST | SensoDetect Aktiebolag (publ) | 0.00 SEK | −27.27% | −97.75% | −99.53% |
| ALNEV.PA | Neovacs S.A. | 0.55 EUR | −31.22% | +6150.00% | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.